Health-related quality of life with adjuvant nivolumab vs. placebo after radical resection for high-risk muscle-invasive urothelial carcinoma: Results from the phase 3 checkmate 274 trial Meeting Abstract


Authors: Gschwend, J. E.; Bajorin, D.; Galsky, M.; Broughton, E.; Braverman, J.; Koon, H.; Maira-Arce, M.; Hamilton, M.; Shi, L.; Guo, S.; Witjes, J. A.
Abstract Title: Health-related quality of life with adjuvant nivolumab vs. placebo after radical resection for high-risk muscle-invasive urothelial carcinoma: Results from the phase 3 checkmate 274 trial
Meeting Title: EAU21 Virtual Congress
Journal Title: European Urology
Volume: 79
Issue: Suppl. 1
Meeting Dates: 2021 Jul 8-12
Meeting Location: Virtual
ISSN: 0302-2838
Publisher: Elsevier Science, Inc.  
Date Published: 2021-06-01
Start Page: S1139
End Page: S1140
Language: English
ACCESSION: WOS:000674144301096
PROVIDER: wos
DOI: 10.1016/S0302-2838(21)01196-9
Notes: Meeting Abstract: P0821 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    657 Bajorin